Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Nasopharyngeal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00006033
What this trial is testing

Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Study completedNCT00021047
What this trial is testing

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Who this might be right for
Esophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Study completedNCT01147991
What this trial is testing

Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer

Who this might be right for
Gastric CancerHead and Neck CancerLymphoma+2 more
Cancer Research UK 16
Large-scale testing (Phase 3)Study completedNCT00201396
What this trial is testing

Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
National Health Research Institutes, Taiwan 480
Testing effectiveness (Phase 2)UnknownNCT04421469
What this trial is testing

Triprilimab(JS001) and Chemotherapy Combined With Local Treatment for Multiple Metastatic NPC

Who this might be right for
Nasopharyngeal Carcinoma
Fujian Cancer Hospital 39
Not applicableLooking for participantsNCT07013461
What this trial is testing

International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
The University of Hong Kong-Shenzhen Hospital 5,000
Not applicableUnknownNCT06265844
What this trial is testing

Multifunctional Nutrition Tube in Dysphagia for Nasopharyngeal Carcinoma

Who this might be right for
Dysphagia
Zeng Changhao 80
Not applicableEnded earlyNCT01254734
What this trial is testing

Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer

Who this might be right for
Recurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Lymphoepithelioma of the NasopharynxRecurrent Lymphoepithelioma of the Oropharynx+52 more
City of Hope Medical Center 7
Not applicableStudy completedNCT04394065
What this trial is testing

UEXPLORER Total-body PET/CT in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 56
Testing effectiveness (Phase 2)Ended earlyNCT02801487
What this trial is testing

Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Shanghai Proton and Heavy Ion Center 6
Large-scale testing (Phase 3)Looking for participantsNCT05062005
What this trial is testing

ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Locally Advanced Nasopharyngeal Carcinoma
First Affiliated Hospital, Sun Yat-Sen University 447
Testing effectiveness (Phase 2)Study completedNCT01349933
What this trial is testing

Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Recurrent Squamous Cell Carcinoma of the NasopharynxStage IV Squamous Cell Carcinoma of the Nasopharynx
National Cancer Institute (NCI) 21
Not applicableActive Not RecruitingNCT06770699
What this trial is testing

Tertiary Lymphoid Structures in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Jiangxi Provincial Cancer Hospital 260
Testing effectiveness (Phase 2)Study completedNCT00003193
What this trial is testing

Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck CancerOral Complications
Massachusetts General Hospital 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06680115
What this trial is testing

Neoadjuvant and Adjuvant Sintilimab Combined with Chemoradiotherapy Versus Chemoradiotherapy Alone in Stage TanyN3M0 Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
First Affiliated Hospital of Guangxi Medical University 150
Post-approval studies (Phase 4)Active Not RecruitingNCT07697287
What this trial is testing

Oral Mucositis Management in Patients Receiving Radiation for Head and Neck Cancer: An Evaluation of a Barrier Based Treatment

Who this might be right for
Squamous Cell CarcinomaOropharyngeal CancersNasopharyngeal Cancer+1 more
McMaster University 29
Testing effectiveness (Phase 2)UnknownNCT05011227
What this trial is testing

Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University 100
Large-scale testing (Phase 3)UnknownNCT01854203
What this trial is testing

Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 300
Testing effectiveness (Phase 2)Looking for participantsNCT06839066
What this trial is testing

A Phase II Study to Evaluate HLX43 in Subjects With Recurrent/Metastatic Nasopharyngeal Carcinoma Failed or Intolerance to Second-line Therapy

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Shanghai Henlius Biotech 70
Large-scale testing (Phase 3)Looking for participantsNCT07328854
What this trial is testing

40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Ming-Yuan Chen 346
Next Page